Native Salts LLC – FDA Warning Letter, Mar 5, 2024
On February 28, 2024, the FDA issued a Warning Letter to Mr. Pickens regarding the distribution of "N, Native Salts," an OTC stimulant drug product. The FDA reviewed the firm's website (https://www.nativesalts.com) on November 15, 2023, and social media (https://www.facebook.com/nativesalts1).
The product is deemed an unapproved new drug under section 505(a) of the FD&C Act (21 U.S.C. 355(a)) and misbranded under section 502(ee) (21 U.S.C. 352(ee)). The FDA cited claims on the website and Facebook, such as "Instant Alertness," "improve energy," "quick jolt of energy when you're tired," and "pick-me-up," as evidence of its intended use as a stimulant.
"N, Native Salts," containing ammonium, eucalyptus oil, peppermint oil, polymer crystals, glycerin, and water, is considered a reflex stimulant and general stimulant. It is an unapproved new drug because no FDA-approved application is in effect. Furthermore, it falls under section 505G(a)(4) of the FD&C Act (21 U.S.C. 355h(a)(4)) as it
ID · 45e5ca18-819c-4097-8fb4-289fe90ee89f
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.